Literature DB >> 1872493

Postmenopausal estrogen and prevention bias.

E Barrett-Connor1.   

Abstract

Mesh：

Year:  1991        PMID： 1872493     DOI： 10.7326/0003-4819-115-6-455

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  47 in total

Review 1.  Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.

Authors:  N K Wenger; D Grady
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Low use of long-term hormone replacement therapy in Denmark.

Authors:  C Olesen; F H Steffensen; H T Sørensen; G L Nielsen; J Olsen; U Bergman
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 3.  Hormones and heart disease: what we thought, what we have learned, what we still need to know.

Authors:  Marian C Limacher
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 4.  Postmenopausal hormone replacement therapy.

Authors:  H S Jacobs; F E Loeffler
Journal:  BMJ       Date:  1992-12-05

Review 5.  Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.

Authors:  William H Shrank; Amanda R Patrick; M Alan Brookhart
Journal:  J Gen Intern Med       Date:  2011-01-04       Impact factor: 5.128

6.  Why do women doctors in the UK take hormone replacement therapy?

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 7.  Healthy aging. A women's issue.

Authors:  A Z La Croix; K M Newton; S G Leveille; J Wallace
Journal:  West J Med       Date:  1997-10

Review 8.  Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Authors:  Nancy Krieger; Ilana Löwy; Robert Aronowitz; Judyann Bigby; Kay Dickersin; Elizabeth Garner; Jean-Paul Gaudillière; Carolina Hinestrosa; Ruth Hubbard; Paula A Johnson; Stacey A Missmer; Judy Norsigian; Cynthia Pearson; Charles E Rosenberg; Lynn Rosenberg; Barbara G Rosenkrantz; Barbara Seaman; Carlos Sonnenschein; Ana M Soto; Joe Thornton; George Weisz
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

9.  The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.

Authors:  A J O'Sullivan; L J Crampton; J Freund; K K Ho
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  Fracture protection provided by long-term estrogen treatment.

Authors:  P Maxim; B Ettinger; G M Spitalny
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.